Home Sonazoid-enhanced ultrasonography and pathologic characters of CD68 positive cell in primary hepatic perivascular epithelioid cell tumors: A case report and literature review
Article Open Access

Sonazoid-enhanced ultrasonography and pathologic characters of CD68 positive cell in primary hepatic perivascular epithelioid cell tumors: A case report and literature review

  • Chen Li , Jing-Yong Xu EMAIL logo and Yuan Liu
Published/Copyright: May 11, 2021

Abstract

Perivascular epithelioid cell tumor (PEComa) is a mesenchymal tumor rarely described in the liver. Sonazoid is a new ultrasound contrast with both vascular and post-vascular phases due to the uptake of Kupffer cell. CD68 is a defined immunohistorical staining marker for macrophage including Kupffer cell. No previous cases have been reported to reveal Kupffer images in the post-vascular phase by using Sonazoid and pathologic characters of CD68 positive cell in PEComa. Herein, we describe the first case to present Sonazoid contrast-enhanced ultrasonography (CEUS) findings in Kupffer images and CD68 positive cell in hepatic PEComa which may lead to rethink of the phagocytic properties of macrophages.

1 Introduction

Perivascular epithelioid cell tumors (PEComas) are mesenchymal tumors with unique perivascular cells found on the histopathology and immunohistochemistry of liver tissue sections [1]. The PEComa family is comprised of angiomyolipomas, lymphangioleiomyomas, and a group of immunohistochemically similar rare tumors arising at various soft tissues and visceral sites often termed as “PEComas-NOS (not otherwise specified)” [2,3,4]. Hepatic PEComas are rare and challenging to diagnose preoperatively because of nonspecific radiologic features.

Contrast-enhanced ultrasonography (CEUS) using Sonazoid, a new-generation ultrasound contrast agent, can provide the “hemodynamic phase” (or “vascular phase”) like other conventional contrast agents. It detected liver masses by the generation of functional images that allow the radiologist to visualize Kupffer cell distributions, defined as “Kupffer-phase” or “post-vascular phase” [5,6]. Only one patient with PEComa, evaluated with Sonazoid CEUS, has been published [7]; however, the Kupffer-phase was not evaluated in that study. Therefore, in this report, we present the novel imaging characteristics of hepatic PEComa using Sonozoid CEUS, including Kupffer-phase characteristics. This imaging was compared with histopathologic examinations and CD68 immunohistochemical staining characteristics of macrophages and Kupffer cells in liver and tumor tissue sections.

2 Case report

We have received informed consent from the patient. A 36-year-old female patient diagnosed with a liver tumor was admitted. The patient was asymptomatic and had no medical history of heavy drinking, oral contraceptives use, hepatitis, or autoimmune disorders. No abnormalities were found on the physical examination or hepatic laboratory functional tests. Serum alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9 (CA19-9) levels were all within normal intervals.

Abdominal ultrasonography revealed a heterogeneous hypoechoic mass in the right lobe of the liver, with well-circumscribed margins (Figure 1a). Color Doppler flow images showed blood flow at the margin of the mass (Figure 1b). Sonazoid CEUS (Figure 1c–f) revealed homogeneous hyper-enhancement in the arterial phase, iso-enhancement in the portal phase, and mild hypo-enhancement in the equilibrium phase. Heterogeneous hypo-enhancement was seen in the post-vascular phase. Transverse abdominal contrast-enhanced computed tomography imaging (Figure 2) demonstrated heterogeneous enhancement during the arterial phase and slightly washout during the portal and equilibrium phases. Traverse abdominal magnetic resonance imaging (MRI) of the mass showed low signal intensities on T1-weighted (T1w, Figure 3a) imaging and high signal intensities on T2-weighted (T2w, Figure 3b) imaging. Dynamic contrast-enhanced MRI showed tumor hyper-intensities in arterial phase images (Figure 3c) and hypo-intensities in the portal phase (Figure 3d).

Figure 1 
               Abdominal ultrasonography and Sonazoid contrast-enhanced ultrasound images (Sonazoid 0.5 mL bolus injection, Toshiba Aplio 500, and 3.75 MHz convex array probe) of a primary hepatic perivascular epithelioid cell tumor. (a) A heterogeneous hypoechoic nodule is demonstrated on B-mode ultrasound (arrows). (b) Color Doppler flow images reveal abundant blood flow at the tumor margins. (c–f) Sonazoid contrast-enhanced ultrasound in the arterial (c, 23 s), portal (d, 100 s), equilibrium (e, 5 min), and post-vascular (f, 10 min) phases. Hyper-enhancement is observed in the arterial phase, with iso-enhancement in the portal phase and mild hypo-enhancement in the equilibrium and post-vascular phases.
Figure 1

Abdominal ultrasonography and Sonazoid contrast-enhanced ultrasound images (Sonazoid 0.5 mL bolus injection, Toshiba Aplio 500, and 3.75 MHz convex array probe) of a primary hepatic perivascular epithelioid cell tumor. (a) A heterogeneous hypoechoic nodule is demonstrated on B-mode ultrasound (arrows). (b) Color Doppler flow images reveal abundant blood flow at the tumor margins. (c–f) Sonazoid contrast-enhanced ultrasound in the arterial (c, 23 s), portal (d, 100 s), equilibrium (e, 5 min), and post-vascular (f, 10 min) phases. Hyper-enhancement is observed in the arterial phase, with iso-enhancement in the portal phase and mild hypo-enhancement in the equilibrium and post-vascular phases.

Figure 2 
               Contrast-enhanced computed tomographic (CT) imaging of a primary hepatic perivascular epithelioid cell tumor in the arterial (a, 25–30 s), portal (b, 60 s), and equilibrium (c, 180 s) phases. A heterogeneous enhancement can be seen during the arterial phase, while the contrast agent was washed out during the portal and equilibrium phases (arrows).
Figure 2

Contrast-enhanced computed tomographic (CT) imaging of a primary hepatic perivascular epithelioid cell tumor in the arterial (a, 25–30 s), portal (b, 60 s), and equilibrium (c, 180 s) phases. A heterogeneous enhancement can be seen during the arterial phase, while the contrast agent was washed out during the portal and equilibrium phases (arrows).

Figure 3 
               Transverse abdominal MRI using different contrasts, including T1-weighted of a primary hepatic perivascular epithelioid cell tumor (a), T2-weighted (b), and dynamic contrast-enhanced magnetic resonance imaging (c and d). The tumor showed low signal intensity on T1-weighted imaging and high signal intensity on T2-weighted imaging (arrows). Hyper-intensity was seen in the arterial phase (25–30 s), while hypo-intensity was seen in the portal phase (60 s).
Figure 3

Transverse abdominal MRI using different contrasts, including T1-weighted of a primary hepatic perivascular epithelioid cell tumor (a), T2-weighted (b), and dynamic contrast-enhanced magnetic resonance imaging (c and d). The tumor showed low signal intensity on T1-weighted imaging and high signal intensity on T2-weighted imaging (arrows). Hyper-intensity was seen in the arterial phase (25–30 s), while hypo-intensity was seen in the portal phase (60 s).

Based on these imaging findings and the medical history, the primary tumor was diagnosed as a hepatic adenoma or atypical hepatocellular carcinoma (HCC).

Resection of liver segment VII was performed. Grossly, the mass was 4.7 × 4 × 3 cm3, brown to gray, and well demarcated from the surrounding liver tissue. On microscopic examination, epithelioid and spindle-shaped cells with oval nuclei and clear to granular eosinophilic cytoplasm were mostly seen. Necrosis and nuclear atypia were inconspicuous (Figure 4). Immunohistochemical staining revealed the tumor cells to be positive for smooth muscle actin (SMA), FLI-1, and TFE3, partially positive for human melanin black-45 (HMB-45), and negative for AE1/AE3, ALK, CK8, Desmin, ERG (UMAB78), GPC3, HCC, LCA, Myogenin, S100, and SOX10. The Ki67 proliferative index was 10%. CD68 staining showed strongly positive macrophages but not Kupffer cells in the tumor. The final diagnosis was hepatic PEComa-NOS.

Figure 4 
               Pathologic and histopathologic findings of a primary hepatic perivascular epithelioid cell tumor. (a) The gross appearance of the tumor on cut dissection shows a well-demarcated brown to gray tumor surrounded by liver tissue. (b) A low power photomicrograph of liver and tumor histopathology using H & E staining (H & E staining ×40). A sharp demarcation between the tumor margin and normal liver parenchyma (star) is observed. (c) A low power photomicrograph of the liver (star) and tumor tissue with CD68 immunohistochemical (IHC) staining (H & E staining ×40); the tumor cells are strongly positive for CD68. (d) and (f) High power photomicrographs of normal liver using H & E and CD68 IHC staining, respectively (H & E staining ×40). (f) Kupffer cells are strongly positive for CD68 and scattered throughout the liver tissue section (arrow). (e) A high power photomicrograph of the tumor with H & E staining (H & E staining ×100). (g) A high power photomicrograph of the tumor using CD68 IHC (H & E staining ×100). CD68 positive cells are densely packed and shaped differently from those of the Kupffer cells in normal liver (arrow).
Figure 4

Pathologic and histopathologic findings of a primary hepatic perivascular epithelioid cell tumor. (a) The gross appearance of the tumor on cut dissection shows a well-demarcated brown to gray tumor surrounded by liver tissue. (b) A low power photomicrograph of liver and tumor histopathology using H & E staining (H & E staining ×40). A sharp demarcation between the tumor margin and normal liver parenchyma (star) is observed. (c) A low power photomicrograph of the liver (star) and tumor tissue with CD68 immunohistochemical (IHC) staining (H & E staining ×40); the tumor cells are strongly positive for CD68. (d) and (f) High power photomicrographs of normal liver using H & E and CD68 IHC staining, respectively (H & E staining ×40). (f) Kupffer cells are strongly positive for CD68 and scattered throughout the liver tissue section (arrow). (e) A high power photomicrograph of the tumor with H & E staining (H & E staining ×100). (g) A high power photomicrograph of the tumor using CD68 IHC (H & E staining ×100). CD68 positive cells are densely packed and shaped differently from those of the Kupffer cells in normal liver (arrow).

The patient recovered with no postoperative complications and was discharged 1 week after surgery. The evidence of recurrence or metastasis was not found during the follow-up period of 16 months.

3 Discussion

In 2013, the World Health Organization (WHO) defined PEComas as mesenchymal tumors composed of distinctive cells showing focal associations with blood vessel walls and usually expressing melanocytic and smooth-muscle markers [8]. Hepatic PEComas are rare and occur primarily in adults with wide age ranges (10–86 years). These tumors are much more frequent in females than males (female-to-male ratio, 2:1 to 5:1) [4]. Most patients are asymptomatic or have no specific clinical symptoms, and the tumors are found incidentally in physical examination. Although the majority of reported PEComas have behaved in a benign fashion, minority have demonstrated malignant behavior with locally destructive recurrence and distant metastasis [9]. However, several other cases can probably exhibit local recurrence or metastasis in long-term follow-up. On histopathology, PEComas are characterized by perivascular locations, and the cells are radially arranged around vascular lumens. Typically, cells around the vessels are epithelioid and spindle-shaped, resembling smooth muscles cells with abundant clear to eosinophilic granular cytoplasm [7,10]. A diagnosis of PEComa usually depends on histopathology and immunohistochemistry [8,11], not on initial diagnostic imaging. PEComas are generally characterized by co-expression of melanocytic markers (HMB-45 and/or Melan-A) and muscle markers (actin and/or desmin) [10]. The tumor, in this case, stained strongly positive for Melan-A, and weakly and partially positive for HMB-45 and SMA, a staining pattern that was key in making a PEComa diagnosis.

The typical ultrasonographic appearance of hepatic PEComa is a well-defined round lesion that is hyperechoic in up to 90% of the cases with high vascularization [12]. Only three liver PEComa cases using CEUS imaging have been reported in English journals [7,13,14]. Sonazoid has been used as a second-generation ultrasound contrast medium in only one case; however, Kupffer imaging in the post-vascular phase has not been reported [7]. SonoVue has been used as another contrast agent in two cases [13,14]. Using SonoVue and Sonazoid contrast agents, homogeneous hyper-enhancements have been obtained in the arterial phase, and iso-enhancement has been seen in the portal vein phase reflected against the surrounding parenchyma. The enhancement patterns in the equilibrium phases were different in PEComas using these two contrast agents; hypo-enhancement was seen using the Sonazoid agent, and persistent slight hyper-enhancement with a lack of rapid washout was observed using the SonoVue agent [7,13,14]. In non-cirrhotic livers, these features can be found in benign lesions such as focal nodular hyperplasia or adenomas, according to the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines [14,15]. Aside from benign lesions, in our case, a differential diagnosis of atypical HCC could not be excluded because of the hypo-enhancement in the equilibrium and post-vascular phases.

Sonazoid is a second-generation sonographic contrast agent initially used in Japan and then licensed in China in 2019. This contrast agent contains lipid-shelled microbubbles that can be easily phagocytosed by Kupffer cells resulting in persistent and stable enhancement periods in hepatic parenchyma. This enhancement is termed the post-vascular or Kupffer phase and begins 10 min after the agent is injected and can last from 1 to 2 h [16]. In this case, tumor hypo-enhancement was seen in the post-vascular phase, which could indicate that fewer Kupffer cells were present in this tumor.

CD68 is expressed in monocyte, macrophage, and Kupffer cell cytoplasm, and can be used to identify Kupffer cells in normal and diseased liver tissue sections [17,18]. We expected that liver tissues containing Kupffer cells or CD68 positive cells would be hyper-enhanced on the Sonazoid CEUS Kupffer or post-vascular phases. However, we saw strongly positive CD68 immunohistochemical staining on the tumor tissue sections, but hypo-enhancement of the tumor in the post-vascular phase on Sonozoid CEUS. CD68 positive cells have been observed in hepatic and renal angiomyolipomas and are relatively common in PEComa family tumors [19,20,21,22]. In our case, it is unclear why so many macrophages were present in the tumor. On high power microscopic examination, a morphologic difference between Kupffer cells in the liver and CD68-positive cells in the tumor was seen. These CD68-positive cells were likely histiocytes, such as migrating macrophages and not Kupffer cells [22]. We speculate that tumor inflammatory responses cause a marked increase in migrating macrophages with decreased functional abilities to uptake the Sonazoid contrast agent. This hypothesis requires further research using Sonazoid CEUS and looking at Kupffer phase images to diagnose hepatic PEComas. Additional research is also needed to study the physiologic mechanisms of PEComas [23].

In conclusion, the PEComa in this study showed hypo-enhancement in the Kupffer or post-vascular phases of Sonazoid CEUS with strongly positive CD68 cell staining on tissue sections. The CD68 cells likely represented migrating macrophages with decreased functional abilities, as opposed to Kupffer cells that would have shown enhanced echogenicity on Sonazoid CEUS. This study provides the first characterization of a PEComa using Sonazoid CEUS, which could be used for the noninvasive diagnosis of PEComas.


tel: +86-138-1035-1797

  1. Conflict of interest: Authors state no conflict of interest.

  2. Data availability statement: All data generated or analyzed during this study are included in this published article.

References

[1] Fletcher CDM, Unni KK, Mertens F. World Health Organization classification of tumors of pathology and genetics of soft tissue and bone. Lyon: IARC Press; 2002. p. 221–2.Search in Google Scholar

[2] Zhao LJ, Yang YJ, Wu H, Huang SM, Liu K. Perivascular epithelioid cell tumor of the liver: a case report and literature review. Eur Rev Med Pharmacol Sci. 2013;17(12):1665–8.Search in Google Scholar

[3] Hekimoglu K, Haberal M. Liver perivascular epithelioid cell tumor with an unusual location: diagnostic characteristics with multidetector computed tomography and magnetic resonance imaging. J Clin Imaging Sci. 2017;7:36. 10.4103/jcis.JCIS_43_17.Search in Google Scholar PubMed PubMed Central

[4] Son HJ, Kang DW, Kim JH, Han HY, Lee MK. Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures. Clin Mol Hepatol. 2017;23(1):80–6. 10.3350/cmh.2016.0034.Search in Google Scholar PubMed PubMed Central

[5] Hatanaka K, Minami Y, Kudo M, Inoue T, Chung H, Haji S. The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US. J Clin Ultrasound. 2014;42(1):1–8. 10.1002/jcu.22080.Search in Google Scholar PubMed

[6] Inoue T, Hyodo T, Korenaga K, Murakami T, Imai Y, Higaki A, et al. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of nonhypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. J Gastroenterol. 2016;51(2):144–52. 10.1007/s00535-015-1094-8.Search in Google Scholar PubMed

[7] Akitake R, Kimura H, Sekoguchi S, Nakamura H, Seno H, Chiba T, et al. Perivascular epithelioid cell tumor (PEComa) of the liver diagnosed by contrast-enhanced ultrasonography. Intern Med. 2009;48(24):2083–6. 10.2169/internalmedicine.48.2133.Search in Google Scholar PubMed

[8] Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. World Health Organization classification of tumors of soft tissue and bone. Vol 5. 4th ed. Lyon: IARC Press; 2013. p. 230–1.Search in Google Scholar

[9] Parfitt JR, Bella AJ, Izawa JI, Wehrli BM. Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med. 2006;130(8):1219–22.10.5858/2006-130-1219-MNOPECSearch in Google Scholar PubMed

[10] Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010;41(1):1–15. 10.1016/j.humpath.2009.05.011.Search in Google Scholar PubMed

[11] Patra S, Vij M, Kota V, Kancherla R, Rela M. Pigmented perivascular epithelioid cell tumor of the liver: report of a rare case with brief review of literature. J Cancer Res Ther. 2013;9(2):305–7. 10.4103/0973-1482.113401.Search in Google Scholar PubMed

[12] Rouquie D, Eggenspieler P, Algayres JP, Bechade D, Camparo P, Baranger B. Malignant-like angiomyolipoma of the liver: report of one case and review of the literature. Ann Chir. 2006;131(5):338–41. 10.1016/j.anchir.2005.11014.Search in Google Scholar

[13] Dezman R, Masulovic D, Popovic P. Hepatic perivascular epithelioid cell tumor: a case report. Eur J Radiol Open. 2018;21(5):121–5. 10.1016/j.ejro.2018.08.004.Search in Google Scholar PubMed PubMed Central

[14] Vigna PD, Preda L, Monfardini L, Gorone MSP, Maffini FA, Bellomi M. Growing perivascular epithelioid cell tumor of the liver studied with contrast-enhanced ultrasonography and magnetic resonance imaging. J Ultrasound Med. 2008;27(12):1781–5. 10.7863/jum.2008.27.12.1781.Search in Google Scholar PubMed

[15] Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34:11–29.10.1055/s-0032-1325499Search in Google Scholar PubMed

[16] Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33:318–25.10.1016/j.ultrasmedbio.2006.08.008Search in Google Scholar PubMed

[17] Greywoode GI, McCarthy SP, McGee JO. Labelling of cells of the mononuclear phagocyte system in routinely processed archival biopsy specimens with monoclonal antibody EBM/11. J Clin Pathol. 1990;43(12):992–6. 10.1136/jcp.43.12.992.Search in Google Scholar PubMed PubMed Central

[18] Mathew J, Hines JE, Toole K, Johnson SJ, James OF, Burt AD. Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology. 1994;25(1):65–70. 10.1111/j.1365-2559.1994.tb00599.x.Search in Google Scholar PubMed

[19] Tochio H, Tamaki E, Imai Y, Iwasaki N, Minowa K, Chung H, et al. CD68-positive cells in hepatic angiomyolipoma. Oncology. 2017;92(Suppl 1):35–9. 10.1159/000451013.Search in Google Scholar PubMed

[20] Tan G, Liu L, Qiu M, Chen L, Cao J, Liu J. Clinicopathologic features of renal epithelioid angiomyolipoma: report of one case and review of literatures. Int J Clin Exp Pathol. 2015;8(1):1077–80.10.1186/s12957-015-0700-9Search in Google Scholar

[21] Hohensee SE, La Rosa FG, Homer P, Suby-Long T, Wilson S, Lucia SM, et al. Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature. J Med Case Rep. 2013;7:118–23. 10.1186/1752-1947-7-118.Search in Google Scholar PubMed PubMed Central

[22] Endo K, Kuroda H, Kakisaka K, Oikawa T, Sawara K, Ishida K, et al. Hepatic Angiomyolipoma staining in the post-vascular phase of contrast-enhanced ultrasound due to the presence of macrophages. Intern Med. 2018;57(9):1247–51. 10.2169/internalmedicine.9697-17.Search in Google Scholar PubMed PubMed Central

[23] Lee S, Kim JH, Lee JH, Zen Y, Han JK. Imaging monitoring of Kupffer cell function and hepatic oxygen saturation in preneoplastic changes during cholangiocarcinogenesis. Sci Rep. 2017;27(1):14203–13. 10.1038/s41598-017-14218-x.Search in Google Scholar PubMed PubMed Central

Received: 2021-01-19
Revised: 2021-03-23
Accepted: 2021-03-24
Published Online: 2021-05-11

© 2021 Chen Li et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Identification of ZG16B as a prognostic biomarker in breast cancer
  3. Behçet’s disease with latent Mycobacterium tuberculosis infection
  4. Erratum
  5. Erratum to “Suffering from Cerebral Small Vessel Disease with and without Metabolic Syndrome”
  6. Research Articles
  7. GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
  8. Expression and role of ABIN1 in sepsis: In vitro and in vivo studies
  9. Additional baricitinib loading dose improves clinical outcome in COVID-19
  10. The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
  11. SLC12A8 plays a key role in bladder cancer progression and EMT
  12. LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
  13. Case Report
  14. Serratia marcescens as a cause of unfavorable outcome in the twin pregnancy
  15. Spleno-adrenal fusion mimicking an adrenal metastasis of a renal cell carcinoma: A case report and embryological background
  16. Research Articles
  17. TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
  18. CircRNA circ_0004370 promotes cell proliferation, migration, and invasion and inhibits cell apoptosis of esophageal cancer via miR-1301-3p/COL1A1 axis
  19. LncRNA XIST regulates atherosclerosis progression in ox-LDL-induced HUVECs
  20. Potential role of IFN-γ and IL-5 in sepsis prediction of preterm neonates
  21. Rapid Communication
  22. COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution
  23. Case Report
  24. Rare squamous cell carcinoma of the kidney with concurrent xanthogranulomatous pyelonephritis: A case report and review of the literature
  25. An infertile female delivered a baby after removal of primary renal carcinoid tumor
  26. Research Articles
  27. Hypertension, BMI, and cardiovascular and cerebrovascular diseases
  28. Case Report
  29. Coexistence of bilateral macular edema and pale optic disc in the patient with Cohen syndrome
  30. Research Articles
  31. Correlation between kinematic sagittal parameters of the cervical lordosis or head posture and disc degeneration in patients with posterior neck pain
  32. Review Articles
  33. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
  34. Research Articles
  35. Thermography in the diagnosis of carpal tunnel syndrome
  36. Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis
  37. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
  38. The influence of smoking in minimally invasive spinal fusion surgery
  39. Impact of body mass index on left atrial dimension in HOCM patients
  40. Expression and clinical significance of CMTM1 in hepatocellular carcinoma
  41. miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway
  42. Comparison of multiple flatfoot indicators in 5–8-year-old children
  43. Early MRI imaging and follow-up study in cerebral amyloid angiopathy
  44. Intestinal fatty acid-binding protein as a biomarker for the diagnosis of strangulated intestinal obstruction: A meta-analysis
  45. miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2
  46. Dynamic perfusion CT – A promising tool to diagnose pancreatic ductal adenocarcinoma
  47. Biomechanical evaluation of self-cinching stitch techniques in rotator cuff repair: The single-loop and double-loop knot stitches
  48. Review Articles
  49. The ambiguous role of mannose-binding lectin (MBL) in human immunity
  50. Case Report
  51. Membranous nephropathy with pulmonary cryptococcosis with improved 1-year follow-up results: A case report
  52. Fertility problems in males carrying an inversion of chromosome 10
  53. Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature
  54. Metastatic renal Ewing’s sarcoma in adult woman: Case report and review of the literature
  55. Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: Two cases reports and literature review
  56. Skull hemophilia pseudotumor: A case report
  57. Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
  58. Adult-onset citrullinaemia type II with liver cirrhosis: A rare cause of hyperammonaemia
  59. Clinicopathologic features of Good’s syndrome: Two cases and literature review
  60. Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review
  61. Research Articles
  62. Effects of hydroxyethyl starch and gelatin on the risk of acute kidney injury following orthotopic liver transplantation: A multicenter retrospective comparative clinical study
  63. Significance of nucleic acid positive anal swab in COVID-19 patients
  64. circAPLP2 promotes colorectal cancer progression by upregulating HELLS by targeting miR-335-5p
  65. Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients
  66. Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
  67. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China
  68. Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis
  69. Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
  70. FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
  71. Platelet-rich fibrin: Basics of biological actions and protocol modifications
  72. Accurate diagnosis of prostate cancer using logistic regression
  73. miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus
  74. Prognostic significance of TRIM28 expression in patients with breast carcinoma
  75. Integrative bioinformatics analysis of KPNA2 in six major human cancers
  76. Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p
  77. A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
  78. Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: Circulating RNAs could explain atherosclerosis disease progression
  79. Propofol postpones colorectal cancer development through circ_0026344/miR-645/Akt/mTOR signal pathway
  80. Knockdown of lncRNA TapSAKI alleviates LPS-induced injury in HK-2 cells through the miR-205/IRF3 pathway
  81. COVID-19 severity in relation to sociodemographics and vitamin D use
  82. Clinical analysis of 11 cases of nocardiosis
  83. Cis-regulatory elements in conserved non-coding sequences of nuclear receptor genes indicate for crosstalk between endocrine systems
  84. Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
  85. Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
  86. Relation between IL-8 level and obstructive sleep apnea syndrome
  87. circAGFG1 sponges miR-28-5p to promote non-small-cell lung cancer progression through modulating HIF-1α level
  88. Nomogram prediction model for renal anaemia in IgA nephropathy patients
  89. Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
  90. NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
  91. A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
  92. Clinical and prognostic features of MMP-2 and VEGF in AEG patients
  93. The value of miR-510 in the prognosis and development of colon cancer
  94. Functional implications of PABPC1 in the development of ovarian cancer
  95. Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy
  96. Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
  97. Prediction of improvement after anterior cruciate ligament reconstruction
  98. Effluent Osteopontin levels reflect the peritoneal solute transport rate
  99. circ_0038467 promotes PM2.5-induced bronchial epithelial cell dysfunction
  100. Significance of miR-141 and miR-340 in cervical squamous cell carcinoma
  101. Association between hair cortisol concentration and metabolic syndrome
  102. Microvessel density as a prognostic indicator of prostate cancer: A systematic review and meta-analysis
  103. Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
  104. Knee alterations in rheumatoid arthritis: Comparison of US and MRI
  105. Long non-coding RNA TUG1 aggravates cerebral ischemia and reperfusion injury by sponging miR-493-3p/miR-410-3p
  106. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p
  107. Development and validation of a nomogram for predicting severity in patients with hemorrhagic fever with renal syndrome: A retrospective study
  108. Analysis of COVID-19 outbreak origin in China in 2019 using differentiation method for unusual epidemiological events
  109. Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
  110. Travelers’ vaccines and their adverse events in Nara, Japan
  111. Association between Tfh and PGA in children with Henoch–Schönlein purpura
  112. Can exchange transfusion be replaced by double-LED phototherapy?
  113. circ_0005962 functions as an oncogene to aggravate NSCLC progression
  114. Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells
  115. Serum intact fibroblast growth factor 23 in healthy paediatric population
  116. Algorithm of rational approach to reconstruction in Fournier’s disease
  117. A meta-analysis of exosome in the treatment of spinal cord injury
  118. Src-1 and SP2 promote the proliferation and epithelial–mesenchymal transition of nasopharyngeal carcinoma
  119. Dexmedetomidine may decrease the bupivacaine toxicity to heart
  120. Hypoxia stimulates the migration and invasion of osteosarcoma via up-regulating the NUSAP1 expression
  121. Long noncoding RNA XIST knockdown relieves the injury of microglia cells after spinal cord injury by sponging miR-219-5p
  122. External fixation via the anterior inferior iliac spine for proximal femoral fractures in young patients
  123. miR-128-3p reduced acute lung injury induced by sepsis via targeting PEL12
  124. HAGLR promotes neuron differentiation through the miR-130a-3p-MeCP2 axis
  125. Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
  126. Cell population data in identifying active tuberculosis and community-acquired pneumonia
  127. Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression
  128. Mean platelet volume and red blood cell distribution width is associated with prognosis in premature neonates with sepsis
  129. 3D-printed porous scaffold promotes osteogenic differentiation of hADMSCs
  130. Association of gene polymorphisms with women urinary incontinence
  131. Influence of COVID-19 pandemic on stress levels of urologic patients
  132. miR-496 inhibits proliferation via LYN and AKT pathway in gastric cancer
  133. miR-519d downregulates LEP expression to inhibit preeclampsia development
  134. Comparison of single- and triple-port VATS for lung cancer: A meta-analysis
  135. Fluorescent light energy modulates healing in skin grafted mouse model
  136. Silencing CDK6-AS1 inhibits LPS-induced inflammatory damage in HK-2 cells
  137. Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC
  138. Severe postoperative hyperbilirubinemia in congenital heart disease
  139. Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway
  140. Clinical factors predicting ureteral stent failure in patients with external ureteral compression
  141. Novel H2S donor proglumide-ADT-OH protects HUVECs from ox-LDL-induced injury through NF-κB and JAK/SATA pathway
  142. Triple-Endobutton and clavicular hook: A propensity score matching analysis
  143. Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis
  144. Serum exosomal miR-122-5p, GAS, and PGR in the non-invasive diagnosis of CAG
  145. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1
  146. Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p
  147. The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
  148. Prognostic value of α2δ1 in hypopharyngeal carcinoma: A retrospective study
  149. No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
  150. circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p
  151. Downregulation of RAB7 and Caveolin-1 increases MMP-2 activity in renal tubular epithelial cells under hypoxic conditions
  152. Educational program for orthopedic surgeons’ influences for osteoporosis
  153. Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma
  154. GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
  155. lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression
  156. Anticoagulation is the answer in treating noncritical COVID-19 patients
  157. Effect of late-onset hemorrhagic cystitis on PFS after haplo-PBSCT
  158. Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
  159. VSTM1 regulates monocyte/macrophage function via the NF-κB signaling pathway
  160. Comparison of vaginal birth outcomes in midwifery-led versus physician-led setting: A propensity score-matched analysis
  161. Treatment of osteoporosis with teriparatide: The Slovenian experience
  162. New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB
  163. Superenhancer–transcription factor regulatory network in malignant tumors
  164. β-Cell function is associated with osteosarcopenia in middle-aged and older nonobese patients with type 2 diabetes: A cross-sectional study
  165. Clinical features of atypical tuberculosis mimicking bacterial pneumonia
  166. Proteoglycan-depleted regions of annular injury promote nerve ingrowth in a rabbit disc degeneration model
  167. Effect of electromagnetic field on abortion: A systematic review and meta-analysis
  168. miR-150-5p affects AS plaque with ASMC proliferation and migration by STAT1
  169. MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
  170. Effects of remifentanil and propofol on distant organ lung injury in an ischemia–reperfusion model
  171. miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway
  172. Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
  173. MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
  174. Dissecting role of founder mutation p.V727M in GNE in Indian HIBM cohort
  175. circATP2A2 promotes osteosarcoma progression by upregulating MYH9
  176. Prognostic role of oxytocin receptor in colon adenocarcinoma
  177. Review Articles
  178. The function of non-coding RNAs in idiopathic pulmonary fibrosis
  179. Efficacy and safety of therapeutic plasma exchange in stiff person syndrome
  180. Role of cesarean section in the development of neonatal gut microbiota: A systematic review
  181. Small cell lung cancer transformation during antitumor therapies: A systematic review
  182. Research progress of gut microbiota and frailty syndrome
  183. Recommendations for outpatient activity in COVID-19 pandemic
  184. Rapid Communication
  185. Disparity in clinical characteristics between 2019 novel coronavirus pneumonia and leptospirosis
  186. Use of microspheres in embolization for unruptured renal angiomyolipomas
  187. COVID-19 cases with delayed absorption of lung lesion
  188. A triple combination of treatments on moderate COVID-19
  189. Social networks and eating disorders during the Covid-19 pandemic
  190. Letter
  191. COVID-19, WHO guidelines, pedagogy, and respite
  192. Inflammatory factors in alveolar lavage fluid from severe COVID-19 pneumonia: PCT and IL-6 in epithelial lining fluid
  193. COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries
  194. What is the role of plasma cell in the lamina propria of terminal ileum in Good’s syndrome patient?
  195. Case Report
  196. Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
  197. CTU findings of duplex kidney in kidney: A rare duplicated renal malformation
  198. Synchronous primary malignancy of colon cancer and mantle cell lymphoma: A case report
  199. Sonazoid-enhanced ultrasonography and pathologic characters of CD68 positive cell in primary hepatic perivascular epithelioid cell tumors: A case report and literature review
  200. Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
  201. Pulmonary parenchymal involvement caused by Tropheryma whipplei
  202. Mediastinal mixed germ cell tumor: A case report and literature review
  203. Ovarian female adnexal tumor of probable Wolffian origin – Case report
  204. Rare paratesticular aggressive angiomyxoma mimicking an epididymal tumor in an 82-year-old man: Case report
  205. Perimenopausal giant hydatidiform mole complicated with preeclampsia and hyperthyroidism: A case report and literature review
  206. Primary orbital ganglioneuroblastoma: A case report
  207. Primary aortic intimal sarcoma masquerading as intramural hematoma
  208. Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review
  209. Peritoneal loose body presenting as a hepatic mass: A case report and review of the literature
  210. Chondroblastoma of mandibular condyle: Case report and literature review
  211. Trauma-induced complete pacemaker lead fracture 8 months prior to hospitalization: A case report
  212. Primary intradural extramedullary extraosseous Ewing’s sarcoma/peripheral primitive neuroectodermal tumor (PIEES/PNET) of the thoracolumbar spine: A case report and literature review
  213. Computer-assisted preoperative planning of reduction of and osteosynthesis of scapular fracture: A case report
  214. High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib
  215. Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
  216. Retrieval of intrarenal coiled and ruptured guidewire by retrograde intrarenal surgery: A case report and literature review
  217. Usage of intermingled skin allografts and autografts in a senior patient with major burn injury
  218. Retraction
  219. Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
  220. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part I
  221. An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
  222. Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2021-0275/html
Scroll to top button